INMED PHARMACEUTICALS INC. Form CORRESP: Company correspondence with SEC staff
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-03-26: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
- 2025-07-31: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
- 2025-07-14: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
- 2024-12-30: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-03-26 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2025-07-31 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2025-07-14 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2024-12-30 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2023-11-09 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2022-12-12 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2022-10-14 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2022-06-27 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2022-04-14 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2022-02-10 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2022-02-09 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2021-07-19 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2021-07-19 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2021-03-11 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2020-11-10 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2020-11-10 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2020-11-10 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2020-11-05 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2020-11-05 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2020-10-08 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2020-09-14 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2020-07-21 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2020-07-20 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2020-07-06 | CORRESP | Company correspondence with SEC staff | filename1.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |